Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
201.8 INR | -1.15% | -2.70% | -2.70% |
Jan. 18 | Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Transcript : Nath Bio-Genes Limited, Q2 2024 Earnings Call, Oct 17, 2023 |
Sales 2022 | 2.78B 33.38M | Sales 2023 | 3.01B 36.14M | Capitalization | 2.68B 32.19M |
---|---|---|---|---|---|
Net income 2022 | -673M -8.07M | Net income 2023 | 350M 4.2M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 888M 10.65M | Net Debt 2023 | 672M 8.06M | EV / Sales 2023 | 1.11 x |
P/E ratio 2022 |
-6.02
x | P/E ratio 2023 |
7.67
x | Employees | 433 |
Yield 2022 |
0.94% | Yield 2023 |
1.42% | Free-Float | 38.47% |
Latest transcript on Nath Bio-Genes (India) Limited
1 day | -1.15% | ||
1 week | -2.70% | ||
Current month | -2.18% | ||
1 month | +5.41% | ||
3 months | -4.22% | ||
6 months | +6.29% | ||
Current year | -2.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director of Finance/CFO | 63 | - | |
Compliance Officer | 30 | 18-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 99-08-29 | |
Director/Board Member | 60 | 12-10-09 | |
Director/Board Member | 42 | 15-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 201.8 | -1.15% | 27,632 |
24-05-02 | 204.2 | -1.04% | 35,033 |
24-04-30 | 206.3 | -1.64% | 39,763 |
24-04-29 | 209.8 | +1.13% | 124,994 |
Delayed Quote NSE India S.E., May 03, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-2.70% | 45.99M | |
+14.54% | 3.36B | |
-95.58% | 1.61B | |
-2.71% | 1.59B | |
-0.56% | 1.28B | |
-.--% | 1.22B | |
-11.54% | 1.21B | |
0.00% | 1.2B | |
+1.22% | 1.18B | |
-12.19% | 1.18B |
- Stock Market
- Equities
- NATHBIOGEN Stock